Advertisement
Subscribe now
Log in
September 22, 2026 23:59
E-Paper
E-Magazine
Corporate
CEO Talk
Biz Link
PR Newswire
Media OutReach Newswire
Investing
M&A
Outbound Investment
Investing in Haiphong
Your Consultant
KPMG
PwC
Indochine Counsel
Vilasia
Ansarada
Green Growth
Energy Efficiency
Rethinking Plastics
BASF
Property
Green Buildings
Industrial Properties
Money
Insurance
Smart Payment Trends
Stock Monitor
Infographics
Timeout
Travel
Hotels & Restaurants
The Insider
Entertainment
Lifestyle
Sports
Photos
Society
CSR
Swing for the Kids
World News
Tags
Specialised Therapeutics
Specialised Therapeutics expands Incyte partnership to market Opzelura in Australia
September 22, 2026 | 22:21
Biopharmaceutical firm Specialised Therapeutics extended its commercial agreement with Incyte Biosciences to handle regulatory registration, distribution, and commercialisation of ruxolitinib cream in Australia.
Latest News
Samsung and Solidigm join Global Memory Innovation Forum speaker lineup
Huawei Electric Power BU outlines AI grid strategies at AESIEAP conference
Convera partners with JustLogin to embed cross-border payroll across Southeast Asia
Specialised Therapeutics expands Incyte partnership to market Opzelura in Australia
Mobile Version